XNCR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: XNCR Shares Outstanding History and XNCR YTD Return |
XNCR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: XNCR Shares Outstanding History and XNCR YTD Return |
XNCR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+18.59% CAGR Mouse over chart for data details
|
XNCR Stock Price Chart |
About Xencor, Inc |
Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Co. is developing a portfolio of clinical-stage XmAb® drug candidates from its protein engineering technology platforms. Co.'s XmAb bispecific Fc drug candidates include: Vudalimab (XmAb717), which is a bispecific antibody that targets PD-1 and CTLA-4 and for patients with metastatic castration-resistant prostate cancer and other solid tumor types; and Plamotamab, which is a bispecific antibody that targets CD20, an antigen on B-cell tumors, and CD3, an activating receptor on T cells. We show 43 historical shares outstanding datapoints in our XNCR shares outstanding history coverage, used to compute XNCR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing XNCR market cap history over the course of time is important for investors interested in comparing XNCR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of XNCR versus a peer is one thing; comparing XNCR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like XNCR can fluctuate over the course of history. With this page we aim to empower investors researching XNCR by allowing them to research the XNCR market cap history. |
XNCR Current Stock Quote |
Free XNCR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
XNCR Share Performance |
Market Cap Peers |
Xencor (XNCR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
XOMA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.